semaglutide oral obesity Four months. That is the entire head start Novo Nordisk's (Wegovy pill) had over Eli Lilly's Foundayo (orforglipron) — and in the commercial dynamics of the world's fastest-growing drug market Wegovy® Pill Guide and Dosing

Food and Drug Administration) Mortality signal: Novo Nordisk tallied 10 deaths and 100+ hospitalizations linked to compounded copies between 2023-24.(Reuters) Quality lapses: Empower Pharmacyone of the largest GLP-1 compoundersreceived its fourth FDA warning letter in April 2025 for sterile-drug deficiencies

Cracks in the pen body, a damaged needle attachment point, or a dose counter that does not function properly may indicate that the pen has been dropped or mishandled

JBMR Plus 3 (10), e10209

Building Trust in Research In an industry where product quality can vary significantly, third-party testing offers reassurance

Wider access to GLP-1 therapies can improve glycaemic control, support weight management, reduce long-term complications, and ultimately ease pressure on the healthcare system